type here...

CATEGORIES

Pharmaceutics

LATEST

1...91011Page 11 of 11

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

The Role of Drugs in Combating Obesity and How These Drugs Affect Your Health

Medika Life -
Obesity cannot be simply cured with a pill but requires a multi-faceted approach to treatment. These drugs will help you to combat obesity in conjunction

Tinder and the White House Want You to Swipe Right on the Covid-19 Vaccine

Dr Jeff Livingston -
Dallas’ own Match Group announced a public health partnership with the Biden White House to help promote Covid-19 vaccination across its portfolio of dating apps

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories